2 CKD confirmatory secondary endpoints Significant 18% RRR of MACE with Ozempic 2 For adults with T2D and CKD, for a confirmatory secondary endpoint: Time to first occurrence of MACE (CV death, nonfatal MI, or nonfatal stroke) vs placebo when both were added to standard of care 1,2 Time to first MACE 1-3,w-z 1-3,w-z w Cumulative incidence estimates are based on time from randomization to first EAC-confirmed MACE with non-CV death modelled as a competing risk using the Aalen-Johnson estimator
NAION occurs when blood flow to the optic disc is blocked, causing swelling which could lead to vision loss
Conversely, suicidal thoughts, intentions, self-harm, attempts, and completed suicides are the focus of consultative psychiatry in patients prescribed GLP-1 RAs
P.TschoppS.BockA.ZehnderC
Doctors disagree "Ozempic doesn't have to be forever." It's a line that may appear on your social media feeds if you've googled how to lose weight, or read up on Hollywood's latest miracle drug: Ozempic
.png)
